Skip to main content

Table 3 Clinical Outcomes

From: Does intravascular ultrasound provide clinical benefits for percutaneous coronary intervention with bare-metal stent implantation? A meta-analysis of randomized controlled trials

Study DIPOL AVID RESIST TULIP OPTICUS Total
  IVUS QCA IVUS QCA IVUS QCA IVUS QCA IVUS QCA IVUS QCA
Patients, n 83 80 369 375 79 76 73 71 273 275 877 877
Death, n (%) 1 (1.2) 1 (1.3) 12 (3.3) 7 (1.9) 1 (1.3) 1 (1.3) 2 (2.7) 1 (1.4) 5 (1.8) 1 (0.36) 21 (2.4) 11 (1.3)
Nonfatal MI, n (%) 1 (1.2) 4 (5) 25 (6.8) 19 (5.1) N/A N/A 1 (1.4) 5 (7.0) 6 (2.2) 10 (3.6) 33 (4.1) 1 38 (4.7) 1
MACE, n (%) 6 (7.2) 13 (16.2) 68 (18.4) 70 (18.7) 20 (25.3) 28 (36.8) 9 (12.3) 19 (26.8) 49 (17.9) 42 (15.3) 152 (17.3) 172 (19.6)
  1. *The analysis of nonfatal MI excludes the RESIST Study, where this outcome was not calculated. MI, myocardial infarction; MACE, major adverse cardiovascular events; IVUS, interventional ultrasound.